Page last updated: 2024-11-05

zolpidem and Dysthymic Disorder

zolpidem has been researched along with Dysthymic Disorder in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Dysthymic Disorder: Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. (DSM-IV)

Research Excerpts

ExcerptRelevanceReference
"Zolpidem is a non-benzodiazepine property which binds selectively to the ?1-GABAA receptors, and has been widely prescribed to patients suffering from insomnia."1.37Zolpidem dependence and withdrawal seizure--report of two cases. ( Chu, CL; Juang, YY; Ree, SC; Wang, LJ, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, LJ1
Ree, SC1
Chu, CL1
Juang, YY1

Other Studies

1 other study available for zolpidem and Dysthymic Disorder

ArticleYear
Zolpidem dependence and withdrawal seizure--report of two cases.
    Psychiatria Danubina, 2011, Volume: 23, Issue:1

    Topics: Adult; Cerebral Cortex; Comorbidity; Depressive Disorder, Major; Dose-Response Relationship, Drug; D

2011